(Q38424462)

3 September 2017

1 reference

title

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? (English)

1 reference

Western African Ebola virus epidemic

3 September 2017

0 references

Orthoebolavirus zairense

0 references

0 references

2

1 reference

3 September 2017

4

1 reference

3 September 2017

5

1 reference

3 September 2017

17

1 reference

3 September 2017

Francesco Vairo

16

0 references

Simone Lanini

Simone Lanini

1

0 references

Giovanni Apolone

Giovanni Apolone

12

0 references

John Ioannidis

3

John P A Ioannidis

1 reference

3 September 2017

Silvio Cavuto

13

0 references

Peter Gottfried Kremsner

15

Peter Kremsner

1 reference

3 September 2017

6

Lawrence Gostin

1 reference

3 September 2017

7

Enrico Girardi

0 references

author name string

Michel Pletschette

8

1 reference

3 September 2017

Gino Strada

9

1 reference

3 September 2017

Aldo Baritussio

10

1 reference

3 September 2017

Gina Portella

11

1 reference

3 September 2017

Roberto Satolli

14

1 reference

3 September 2017

14 April 2015

1 reference

Lancet Infectious Diseases

3 September 2017

1 reference

3 September 2017

15

1 reference

3 September 2017

6

1 reference

3 September 2017

738-745

1 reference

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Ebola and travel--management of imported cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Randomised controlled trials for Ebola: practical and ethical issues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Evaluating Ebola therapies--the case for RCTs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Improving the drug development process: more not less randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Clinical care of two patients with Ebola virus disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Potential and emerging treatment options for Ebola virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

A case of severe Ebola virus infection complicated by gram-negative septicemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Anti-inflammatory effect of Qingwen Baidu Decoction (清瘟败毒饮) in sepsis rats

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Xuebijing injection reduces organ injuries and improves survival by attenuating inflammatory responses and endothelial injury in heatstroke mice

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

The first case of Ebola virus disease acquired outside Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Ethics in cooperative clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Randomized clinical trials. Perspectives on some recent ideas

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Ethics and statistics in randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

The ethical problem of randomization

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Doing today's work superbly well--treating Ebola with current tools

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Mapping the translational science policy 'valley of death'

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

What makes clinical research ethical?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Trials at the ready: preparing for the next pandemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Randomisation is essential in Ebola drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Adaptive design methods in clinical trials - a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Evaluating novel therapies during the Ebola epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Adaptive trials in clinical research: scientific and ethical issues to consider.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

Viral hemorrhagic fevers: advancing the level of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2815%2970106-4

7 January 2021

The randomized controlled clinical trial. Scientific and ethical bases.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25881871

12 December 2020

inferred from PubMed ID database lookup

Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25881871

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1016/S1473-3099(15)70106-4

1 reference

3 September 2017

1 reference